This product is intended strictly for laboratory research use only, including in vitro testing and non-clinical experimentation
Cost: Saxenda costs $1349.02 per month without insurance
D.WilksA
Study Design Type: Phase 2, double-blind, randomized, placebo-controlled study Participants: 338 adults (BMI 30 or BMI 27 with a coexisting condition) Groups: Retatrutide 1 mg, 4 mg, 8 mg, 12 mg (different initial doses 2 or 4 mg) and placebo Duration: 48 weeks (plus 4 weeks follow-up) Administration: subcutaneous, 1x weekly Primary endpoint: percentage change in body weight at week 24 Secondary endpoints: change in weight at week 48, 5%, 10%, 15% weight reduction
JAMA Psychiat
Additionally, informing your healthcare provider if youre pregnant or breastfeeding is essential, as Vitamin B12 injections may not be safe in these circumstances